Award recordCONTRACT

GLAXOSMITHKLINE, LLC

PIID 36E79726D0030· VA Staff Offices· NAC PHARMACEUTICALS (36E797)· 6505 · DRUGS AND BIOLOGICALS· FY2026· $0 net obligations· UEI FRHTPHMZMX47· NC

Description

MODIFICATION INCORPORATES SECTION 5 OF EO 14398, CLAUSE 52.222-90, ADDRESSING DEI DISCRIMINATION

Base award description: NEW AWARD FOR FLUTICASONE/SALMETEROL INHALERS WITH GLAXOSMITHKLINE. ORDERING PERIOD IS AUGUST 1, 2026 - JULY 31, 2027 WIT FOUR ONE-YEAR OPTIONS.

First action · last action
2026-05-26 · 2026-08-31
Transactions
2
First transaction's obligation
$0
Base + all options value (sum of deltas)
$182,885,824
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
7
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$1$0Base award · 2026-05-26 · this action $0 · running total $0Modification P00001 · 2026-08-31 · this action $0 · running total $0
  • Base2026-05-26+$0= $0
  • Mod P000012026-08-31+$0= $0
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2026-05-26+$0$0NEW AWARD FOR FLUTICASONE/SALMETEROL INHALERS WITH GLAXOSMITHKLINE. ORDERING PERIOD IS AUGUST 1, 2026 - JULY…
Mod P00001· OTHER ADMINISTRATIVE ACTION2026-08-31+$0$0MODIFICATION INCORPORATES SECTION 5 OF EO 14398, CLAUSE 52.222-90, ADDRESSING DEI DISCRIMINATION

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI FRHTPHMZMX47)

AwardOffice · PSC / listingNet obligationsFY
36C77024F0047NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$3,166FY2024
36C24124F0121241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS$39,180FY2024
36C24124F0119241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS$33,793FY2024
36C24624N0685246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6505 · DRUGS AND BIOLOGICALS$58,770FY2024
36C24624N0682246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6505 · DRUGS AND BIOLOGICALS$19,590FY2024
36C24624N0687246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6505 · DRUGS AND BIOLOGICALS$117,540FY2024

Other recipients under 6505 from NAC PHARMACEUTICALS (36E797) (most recent first)

AwardRecipientOfficeNet obligationsFY
36E79726A0025CHIESI USA INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0024NEUROTECH PHARMACEUTICALS, INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0023TAKEDA PHARMACEUTICALS AMERICA, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726D0041GOLDEN STATE MEDICAL SUPPLY, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0022AURINIA PHARMA US INCNAC PHARMACEUTICALS (36E797)$0FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36E79726D0030_3600 · retrieved 2026-09-26.